Abbott launches new assay for vector-borne pathogens

Abbott has announced the launch of a new molecular assay for use in the detection of common vector-borne pathogens.

The company's subsidiary Ibis Biosciences has developed the Plex-ID Vector-borne test, a single broad-range assay that can identify a wide array of microorganisms using a single specimen.

It is designed for non-diagnostic applications in fields such as bioresearch and can be used to detect bacteria that can cause conditions such as Lyme disease, babesiosis, ehrlichiosis and anaplasmosis.

Researchers have demonstrated during a US-based assessment of blacklegged ticks that the Ibis technology is able to detect pathogens faster than traditional laboratory methods.

Dr Mark Eshoo, director of new technology development at Ibis Biosciences, said: "The test can identify protozoa, bacteria and nematodes, in a wide range of specimen types, including ticks, fleas, blood or tissue."

According to fiscal data published by Abbott last month, the company saw a nine percent year-on-year rise in global sales in the second quarter of 2011.